Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “FIGO Stage III Cervix Carcinoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT00086242
What this trial is testing

Telephone Counseling or Standard Care in Patients Who Have Completed Treatment for Stages I, II, or III Cervical Cancer

Who this might be right for
Cervical CancerPsychosocial Effects of Cancer and Its Treatment
University of California, Irvine 36
Testing effectiveness (Phase 2)Study completedNCT00369122
What this trial is testing

Bevacizumab, Radiation Therapy, and Cisplatin in Treating Patients With Previously Untreated Locally Advanced Cervical Cancer

Who this might be right for
Cervical AdenocarcinomaCervical Adenosquamous CarcinomaCervical Squamous Cell Carcinoma, Not Otherwise Specified+4 more
National Cancer Institute (NCI) 60
Not applicableStudy completedNCT00004936
What this trial is testing

MRI and CT Scans to Evaluate Invasive Cervical Cancer Before Treating Patients

Who this might be right for
Cervical Cancer
American College of Radiology Imaging Network
Testing effectiveness (Phase 2)Study completedNCT00101192
What this trial is testing

Cetuximab and Cisplatin in Treating Patients With Advanced, Persistent, or Recurrent Cervical Cancer

Who this might be right for
Cervical Cancer
Gynecologic Oncology Group 76
Early research (Phase 1)Study completedNCT00287885
What this trial is testing

Docetaxel in Treating Patients With Refractory or Recurrent Advanced Gynecologic Cancer

Who this might be right for
Cervical CancerEndometrial CancerFallopian Tube Cancer+5 more
Masonic Cancer Center, University of Minnesota 18
Testing effectiveness (Phase 2)Study completedNCT00404326
What this trial is testing

Hydralazine and Valproate Plus Cisplatin Chemoradiation in Cervical Cancer

Who this might be right for
Cervical Cancer
National Institute of Cancerología 18
Testing effectiveness (Phase 2)WithdrawnNCT00452920
What this trial is testing

Docetaxel and Radiation Therapy in Treating Patients With Stage II, Stage III, or Stage IV Cervical Cancer

Who this might be right for
Cervical Cancer
University of Miami
Testing effectiveness (Phase 2)Study completedNCT00941070
What this trial is testing

Triapine, Cisplatin, and Radiation Therapy in Treating Patients With Cervical Cancer or Vaginal Cancer

Who this might be right for
Recurrent Cervical CancerRecurrent Vaginal CancerStage IB Cervical Cancer+10 more
National Cancer Institute (NCI) 26
Early research (Phase 1)Study completedNCT00020579
What this trial is testing

MS-275 in Treating Patients With Advanced Solid Tumors or Lymphoma

Who this might be right for
Cancer
National Institutes of Health Clinical Center (CC) 75
Early research (Phase 1)Study completedNCT00098995
What this trial is testing

Tirapazamine, Cisplatin, and Radiation Therapy in Treating Patients With Stage IB, Stage II, Stage III, or Stage IVA Cervical Cancer

Who this might be right for
Cervical Cancer
Peter MacCallum Cancer Centre, Australia 22
Testing effectiveness (Phase 2)Study completedNCT00087113
What this trial is testing

Pemetrexed Disodium in Treating Patients With Recurrent Cancer of the Cervix

Who this might be right for
Cervical Cancer
Gynecologic Oncology Group
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07368985
What this trial is testing

Pembrolizumab and Lenvatinib in Patients With High Risk Locally Advanced Cervix Cancer

Who this might be right for
Cervical Cancer by FIGO Stage 2018Squamous Cell Carcinoma FIGO 2018 Stage IIIA, IIIB, IIIC1-IIIC2Adenocarcinoma or Adeno-squamous Carcinoma Stage IB3-IIIC2
Prof. Dr. Remi A. Nout 87
Not applicableStudy completedNCT00915889
What this trial is testing

Psychosocial Support for African-American, Latina-American, or European-American Cervical Cancer Survivors

Who this might be right for
Cancer SurvivorCervical CancerPsychosocial Effects of Cancer and Its Treatment
City of Hope Medical Center 340
Early research (Phase 1)Study completedNCT00002949
What this trial is testing

Vinorelbine and Paclitaxel Plus Radiation Therapy in Treating Patients With Advanced Cancer Arising in the Pelvis

Who this might be right for
Bladder CancerCervical CancerEndometrial Cancer+1 more
University of Chicago 33
Early research (Phase 1)Study completedNCT00878995
What this trial is testing

Testosterone for Treating Cachexia in Patients With Squamous Cell Carcinoma

Who this might be right for
CachexiaSquamous Cell Carcinoma
The University of Texas Medical Branch, Galveston 28
Large-scale testing (Phase 3)UnknownNCT01917695
What this trial is testing

Study on Early Stage Bulky Cervical Cancers

Who this might be right for
Carcinoma Cervix
Rajkumar Kottayasamy Seenivasagam 180
Early research (Phase 1)Study completedNCT00005842
What this trial is testing

Trastuzumab Plus R115777 in Treating Patients With Advanced or Metastatic Cancer

Who this might be right for
Cancer
National Cancer Institute (NCI) 24
Not applicableStudy completedNCT00735514
What this trial is testing

Compliance to Vaginal Dilation Therapy in Patients Who Have Undergone Radiation Therapy For Stage IB, Stage IIA, Stage IIB, Stage IIIA, or Stage IIIB Cervical Cancer or Stage IA, Stage IB, Stage IIA, or Stage IIB Endometrial Cancer

Who this might be right for
Cervical CancerEndometrial CancerRadiation Toxicity+1 more
Case Comprehensive Cancer Center 83
Not applicableStudy completedNCT03198286
What this trial is testing

Carevive Survivor Care Planning System in Improving Quality of Life in Breast Cancer Survivors

Who this might be right for
Stage I Breast CancerStage I Cervical CancerStage I Ovarian Cancer+36 more
Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University 40
Testing effectiveness (Phase 2)Ended earlyNCT00003624
What this trial is testing

Amifostine in Treating Women With Ovarian, Peritoneal, Cervical, Fallopian Tube, Uterine, or Endometrial Cancer

Who this might be right for
Cervical CancerEndometrial CancerFallopian Tube Cancer+4 more
Gynecologic Oncology Group
Next Page